Portfolio Diversification
Range
Most Diversified
30 instruments
March 2, 2022
Least Diversified
0 instruments
February 1, 2022
Average
29.1 instruments
Most Consistent Holdings
Top 5
JNJ97.44%
MRK97.44%
PFE97.44%
AMGN97.44%
ABBV97.44%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Number of Instruments
Holdings over time
(Since February 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Eli Lilly (LLY) | 3.92% | 3.55% | 97.44% | - |
 Bridgebio (BBIO) | 3.87% | 3.95% | 71.44% | - |
 Vertex (VRTX) | 3.62% | 3.88% | 97.44% | - |
 ImmunoGen Inc (IMGN) | 3.54% | 0% | 60.57% | 2/14/2024 |
| Merck (MRK) | 3.35% | 3.05% | 97.44% | - |
 Regeneron (REGN) | 3.28% | 2.81% | 97.44% | - |
| Johnson & Johnson (JNJ) | 3.25% | 3.24% | 97.44% | - |
 Gilead Sciences (GILD) | 3.22% | 3.93% | 97.44% | - |
| AbbVie (ABBV) | 3.14% | 3.48% | 97.44% | - |
 Exact Sciences (EXAS) | 3.14% | 4.39% | 97.44% | - |
| Amgen (AMGN) | 3.13% | 3.62% | 97.44% | - |
 Bristol-Myers Squibb (BMY) | 3.11% | 3.25% | 97.44% | - |
 CRISPR Therapeutics (CRSP) | 3.08% | 0% | 88.33% | 12/26/2024 |
 Guardant Health (GH) | 3.04% | 6.07% | 97.44% | - |
 Illumina (ILMN) | 3.01% | 2.5% | 97.26% | - |
| Pfizer (PFE) | 2.91% | 3.05% | 97.44% | - |
 Iovance (IOVA) | 2.41% | 1.64% | 71.44% | - |
 Argenx (ARGX) | 2.36% | 2.97% | 71.44% | - |
 Revolution Medicines (RVMD) | 2.36% | 2.78% | 71.44% | - |
 Blueprint Medicines (BPMC) | 2.32% | 3.07% | 71.44% | - |
 Exelixis (EXEL) | 2.31% | 3.22% | 65.96% | - |
 Syndax (SNDX) | 2.13% | 2.68% | 71.44% | - |
 Mirati Therapeutics Inc (MRTX) | 1.79% | 0% | 59.33% | 1/31/2024 |
 Arcellx (ACLX) | 1.59% | 2.79% | 40.67% | - |
 BeiGene (ONC) | 1.57% | 0% | 56.76% | 1/2/2024 |
 SpringWorks Therapeutics (SWTX) | 1.41% | 3.46% | 40.67% | - |
 Fate Therapeutics (FATE) | 1.41% | 0% | 56.76% | 1/2/2024 |
 Seagen Inc (SGEN) | 1.31% | 0% | 29.44% | 12/18/2023 |
 AstraZeneca (AZN) | 1.29% | 3.2% | 40.67% | - |
 TG Therapeutics (TGTX) | 1.28% | 4.27% | 35.19% | - |
 Crinetics (CRNX) | 1.28% | 0% | 31.56% | 12/26/2024 |
 BD (BDX) | 1.17% | 2.99% | 40.67% | - |
 Legend Biotech (LEGN) | 1.08% | 0% | 30.77% | 1/2/2024 |
 Incyte (INCY) | 1.07% | 0% | 25.99% | 1/12/2023 |
 Zai Lab (ZLAB) | 1% | 3.49% | 39.88% | - |
 BioNTech SE (BNTX) | 0.99% | 0% | 25.99% | 1/12/2023 |
 2Seventy Bio (TSVT) | 0.98% | 0% | 25.99% | 1/12/2023 |
 Option Care Health (OPCH) | 0.97% | 0% | 31.56% | 12/26/2024 |
 Rocket (RCKT) | 0.89% | 0% | 31.56% | 12/26/2024 |
 Arvinas (ARVN) | 0.89% | 0% | 31.56% | 12/26/2024 |
 Agenus (AGEN) | 0.88% | 0% | 25.99% | 1/12/2023 |
 LabCorp (LH) | 0.86% | 0% | 25.99% | 1/12/2023 |
 GlaxoSmithKline (GSK) | 0.81% | 0% | 25.99% | 1/12/2023 |
 MannKind (MNKD) | 0.8% | 0% | 30.77% | 1/2/2024 |
 Sorrento (SRNE) | 0.7% | 0% | 25.99% | 1/12/2023 |
 Celldex (CLDX) | 0.67% | 0% | 30.77% | 1/2/2024 |
 Inovio (INO) | 0.66% | 0% | 25.99% | 1/12/2023 |
 Clovis Oncology Inc (CLVSQ) | 0.59% | 0% | 24.23% | 12/22/2022 |
 Surface Oncology Inc (SURF) | 0.44% | 0% | 24.23% | 12/22/2022 |
 Invitae Corp (NVTAQ) | 0.33% | 0% | 25.99% | 1/12/2023 |
 Scholar Rock (SRRK) | 0.32% | 2.71% | 9.11% | - |
 Halozyme (HALO) | 0.32% | 4.05% | 9.11% | - |
 Curis (CRIS) | 0.3% | 0% | 24.23% | 12/22/2022 |
 Merus (MRUS) | 0.26% | 2.82% | 9.11% | - |
 Janux (JANX) | 0.21% | 1.69% | 9.11% | - |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2025
| Instrument | Invested | Value |
|---|---|---|
| Exact Sciences (EXAS) | 6.26% | 5.15% |
| Illumina (ILMN) | 3.69% | 4.17% |
| Scholar Rock (SRRK) | 4.72% | 4.1% |
| Guardant Health (GH) | 5.47% | 4.06% |
| Iovance (IOVA) | 3.5% | 3.67% |
| Revolution Medicines (RVMD) | 2.45% | 3.54% |
| Eli Lilly (LLY) | 1.71% | 3.46% |
| Arcellx (ACLX) | 2.82% | 3.45% |
| Merck (MRK) | 3.47% | 3.42% |
| Janux (JANX) | 3.87% | 3.39% |
| Pfizer (PFE) | 4.88% | 3.27% |
| Bridgebio (BBIO) | 1.42% | 3.23% |
| Regeneron (REGN) | 3.22% | 3.2% |
| TG Therapeutics (TGTX) | 2.05% | 3.15% |
| Gilead Sciences (GILD) | 2.42% | 3.15% |
| SpringWorks Therapeutics (SWTX) | 3.48% | 3.09% |
| Blueprint Medicines (BPMC) | 2.02% | 3.05% |
| Argenx (ARGX) | 2.14% | 3.04% |
| Bristol-Myers Squibb (BMY) | 3.69% | 3.04% |
| AbbVie (ABBV) | 2.8% | 3.03% |
| BD (BDX) | 3.58% | 3.02% |
| Vertex (VRTX) | 1.98% | 3.01% |
| Halozyme (HALO) | 3.28% | 2.98% |
| Amgen (AMGN) | 3.03% | 2.98% |
| Syndax (SNDX) | 5.42% | 2.94% |
| AstraZeneca (AZN) | 3.33% | 2.91% |
| Merus (MRUS) | 3.26% | 2.9% |
| Zai Lab (ZLAB) | 3.28% | 2.89% |
| Johnson & Johnson (JNJ) | 3.51% | 2.84% |
| Exelixis (EXEL) | 2.1% | 2.82% |